Paragon Financial Partners’s AbbVie ABBV Stock Holding History

Paragon Financial Partners’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$378K	Hold	1,797	–	–	0.21%	58
2025 Q4	$410K	Buy	1,797 +1	+0.1%	+$228	0.25%	53
2025 Q3	$416K	Buy	1,796 +1	+0.1%	+$204	0.26%	50
2025 Q2	$333K	Hold	1,795	–	–	0.23%	57
2025 Q1	$376K	Buy	1,795 +1	+0.1%	+$194	0.29%	50
2024 Q4	$319K	Sell	1,794 -3,059	-63%	-$562K	0.24%	57
2024 Q3	$958K	Buy	4,853 +1	+0%	+$187	0.7%	28
2024 Q2	$832K	Hold	4,852	–	–	0.65%	27
2024 Q1	$883K	Buy	4,852 +1	+0%	+$172	0.73%	25
2023 Q4	$752K	Sell	4,851 -256	-5%	-$37.3K	0.72%	23
2023 Q3	$761K	Hold	5,107	–	–	0.79%	22
2023 Q2	$688K	Buy	5,107 +1	+0%	+$147	0.65%	26
2023 Q1	$814K	Buy	5,106 +8	+0.2%	+$1.22K	0.85%	21
2022 Q4	$824K	Buy	5,098 +1,846	+57%	+$283K	0.91%	21
2022 Q3	$437K	Sell	3,252 -926	-22%	-$133K	0.49%	35
2022 Q2	$640K	Buy	4,178 +50	+1%	+$7.64K	0.66%	26
2022 Q1	$669K	Hold	4,128	–	–	0.58%	30
2021 Q4	$559K	Buy	+4,128	New	+$488K	0.46%	44

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Paragon Financial Partners's ABBV Position: Q1 2026 in Review

Paragon Financial Partners held its AbbVie (ABBV) position steady in Q1 2026 at 1,797 shares worth $378K. The position accounts for 0.21% of the portfolio, ranked #58.

Paragon Financial Partners first reported a position in ABBV in Q4 2021 and has held it in 18 quarters since. The position peaked at $958K in Q3 2024. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Paragon Financial Partners held 1,797 shares of AbbVie worth $378K as of Q1 2026.
Paragon Financial Partners left its AbbVie share count unchanged in Q1 2026.
AbbVie made up 0.21% of Paragon Financial Partners's portfolio in Q1 2026, its #58 holding.
Paragon Financial Partners first reported a position in AbbVie in Q4 2021 and has held it in 18 quarters since.
Paragon Financial Partners's AbbVie position peaked at $958K in Q3 2024.
4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Paragon Financial Partners's 13F filing for Q1 2026, filed 17 Apr 2026.